According to changes in the levels of mRNAs and miRNA-targeted mRNAs, the programmed death-1 (PD-1) and programmed cell death ligand 1 (PD-L1) cancer immunotherapy pathway was the most activated in these analyses, whereas the Th2 pathway was the most inhibited pathway. The gene discussed is PDCD1; the disease is cancer.